Declining Risk of Sudden Death in Heart FailureLi Shen, John J.V. McMurray, Luigi Tavazzi et al.|New England Journal of Medicine|2017Cited by 500
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trialJohn G.F. Cleland, Theis Lange, João Pedro Ferreira et al.|European Heart Journal|2020Cited by 143
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart FailureJoão Pedro Ferreira, Faı̈ez Zannad, Job A.J. Verdonschot et al.|Circulation Heart Failure|2019Cited by 97
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in MacrophagesClaudia Meda, Enrico Giraudo, Fabiola Molla et al.|The Journal of Immunology|2012Cited by 81
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rosselló, John Munkhaugen, Eva Prescott et al.|The Lancet|2025Cited by 63